Improving community engagement for rheumatic and musculoskeletal diseases
Dissemination and Implementation for Community Engagement
This study is all about getting more people, especially those from different backgrounds, involved in research about rheumatic and musculoskeletal diseases, using fun and creative ways like social media, so we can work together to improve health for everyone.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10928419 on NIH RePORTER |
What this research studies
This research focuses on enhancing community engagement and participation in studies related to rheumatic and musculoskeletal diseases (RMDs). It aims to recruit diverse populations, particularly underrepresented racial and ethnic groups, through innovative strategies such as online communities and social media campaigns. By collaborating with patients, advocates, and communities, the project seeks to ensure that these groups are meaningfully involved in research efforts, ultimately striving for health equity and improved health outcomes. The DICE Core will provide resources and support to facilitate this engagement and recruitment process.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals from underrepresented racial and ethnic backgrounds living with rheumatic and musculoskeletal diseases.
Not a fit: Patients who do not have rheumatic and musculoskeletal diseases or those who are not part of underrepresented groups may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and greater representation of diverse populations in RMD studies.
How similar studies have performed: Similar research efforts have shown promise in improving engagement and representation in clinical studies, indicating that this approach could be effective.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Hidalgo, Bertha — University of Alabama at Birmingham
- Study coordinator: Hidalgo, Bertha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.